Our weekly round-up of the bright young things and big cheeses in pharmaceuticals.
Former GSK executive Agnes Westelinck has announced she will join regulatory consultancy NDA Partners as a Premier Expert Consultant.
Westelinck was Executive Director and Global Head of Regulatory Affairs for Oncology at GlaxoSmithKline from 2010 to 2014. She previously worked in regulation for Hoffman-La Roche, Barrier Therapeutics, Schering-Plough, Fournier Pharma and UCB.
As a consultant for NDA Partners Westelinck will advise clients developing medical products about regulatory pathways and access to global markets, and help make their companies attractive to investors.
The 40-strong strategy consultancy began in 2003 advising emerging pharmaceuticals companies and life sciences investment funds, and now works with pharma multinationals entering the US market as well as R&D-oriented government agencies.
Copyright - Unless otherwise stated all contents of this web site are © 2015 - William Reed Business Media SAS - All Rights Reserved - Full details for the use of materials on this site can be found in the Terms & Conditions